Drugs / T10430
last change Jan 2026 re-read 3 minutes ago

T10430

Developed for
myopia
Investigated by
Laboratoires Thea

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07522242 Jan 2026 → Nov 2027 expected myopia Laboratoires Thea Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as T10430 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07522242 ↗